Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
David W Andrews;Charles B Scott;Paul W Sperduto;Adam E Flanders.
The Lancet (2004)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu.
Journal of Clinical Oncology (2012)
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins.
Journal of Clinical Oncology (2013)
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi;Stephanie L. Pugh;Wolfgang A. Tome;Chip Caine.
Journal of Clinical Oncology (2014)
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Paul W. Sperduto;Brian Berkey;Laurie E. Gaspar;Minesh Mehta.
International Journal of Radiation Oncology Biology Physics (2008)
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo.
International Journal of Radiation Oncology Biology Physics (2009)
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp.
Journal of Clinical Oncology (2008)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp.
Journal of Clinical Oncology (2013)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner;Edward G. Shaw;Stephanie L. Pugh;Arnab Chakravarti.
The New England Journal of Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
National Institutes of Health
Emory University
Cleveland Clinic
Harvard University
Princess Margaret Cancer Centre
University of Colorado Denver
University of California, San Francisco
University of Maryland, Baltimore
University of California, Los Angeles
Simon Fraser University
University of California, Berkeley
Zhejiang University
Chongqing University
Chinese Academy of Sciences
University of Freiburg
Chubu University
Texas A&M University
Max Planck Society
Washington University in St. Louis
Centre national de la recherche scientifique, CNRS
University of Miami
Okayama University
Case Western Reserve University
New York Medical College
McMaster Children's Hospital